首页 > 市场调查报告书 > 医疗设备

导管药物递输设备

市场调查报告书

商品编码

1634180

全球医疗管材市场 - 2025 - 2033

Global Medical Tubing Market - 2025 - 2033

出版日期: 2025年01月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球医疗管材市场规模达112.5亿美元，预估至2033年将达224.7亿美元，2025-2033年预测期间复合年增长率为8.3%。

医用管是一种柔性的中空导管，用于在体内或医疗设备与患者之间输送液体、气体或其他物质。其设计对于安全有效地施用药物、营养素和其他治疗物质至关重要。医用管材由多种生物相容性材料製成，包括硅胶、PVC（聚氯乙烯）、聚氨酯和热塑性塑胶。选择这些材料是因为它们具有灵活性、耐用性和耐化学性。这种适应性使医用管材能够用于多种应用，包括静脉 (IV) 治疗、呼吸支持和外科手术。

对微创手术的需求不断增长是预测期内推动市场的驱动因素。由于对微创手术的需求不断增加，导管等设备的製造和推出正在蓬勃发展，技术的进步也在最近推出的产品中得到体现。例如，2024年5月，Penumbra推出了MIDWAY 43和MIDWAY 62输送导管，旨在为神经血管系统中各种栓塞治疗的输送提供最佳追踪和稳定平台。这些 MIDWAY 中间导管基于 Penumbra 的 RED 导管技术，是中间接入器械产业的重大改进。

市场动态：

驱动程式和限制

微创手术的需求不断增加

微创手术切口较小，对身体的伤害较小，由于其多种优点，逐渐取代传统的开放性手术。这些手术通常可以加快復健速度、降低併发症风险、减少术后疼痛并缩短住院时间。因此，患者和医疗保健从业人员越来越多地采用这些程序，从而导致对实施这些程序所需的专用医疗管的需求增加。

医用管在心臟病学、胃肠病学、泌尿外科和神经外科等医学专业的各种微创治疗中至关重要。例如，导管和导丝是血管成形术和内视镜治疗中的关键组件。这些管道必须经过精确设计，才能成功输送药物或设备，同时维护病人安全。内视镜检查的数量日益增加。数量的增加增加了对医用管材的需求。例如，根据 2024 年的一项全球调查，约 32% 的外科医生表示，他们每年进行 100 多次内视镜检查手术。另有 13.6% 的受访外科医生一年进行 50 至 99 次内视镜检查。

近年来，采用先进技术的各医疗专科医用管材产品不断推出。例如，2023 年 1 月，半导体解决方案製造商 Omnivision 推出了新型 OVMed OCHTA，这是一种用于一次性内视镜的超薄医疗级电缆模组。新模组专为微创手术中使用的内视镜而设计，例如脊椎、妇产科、子宫肾、神经、眼科和心臟手术。 OVMed OCHTA 电缆模组具有六线电缆，使製造商能够添加自己的 LED 照明。

生产成本高

高生产成本等因素预计将阻碍全球医用管材市场的发展。医疗管製造包括许多复杂的零件和工艺，每一个零件和工艺都会增加总支出。高品质的原材料、严格的监管合规性以及创新的製造程序都会导致更高的生产成本。例如，与传统聚合物相比，医用级有机硅的生产成本可能会增加 20-30%。挤压机械的价格在 10 万美元到 50 万美元之间，具体取决于其复杂性和产量。挤出机械对于确保整个管材的均匀性至关重要。所有这些材料成本、挤出机成本和监管合规审批成本加起来相当大，这使得产量很高并阻碍了市场。

Medical tubing is a flexible, hollow conduit intended for transporting fluids, gasses, or other substances within the body or between medical devices and patients. Its design is critical for providing the safe and effective administration of medicines, nutrients, and other therapeutic substances. Medical tubing is constructed from a variety of biocompatible materials, including silicone, PVC (polyvinyl chloride), polyurethane, and thermoplastics. These materials are chosen for their flexibility, durability, and chemical resistance. This adaptability enables medical tubing to be employed in a variety of applications, including intravenous (IV) therapy, respiratory support, and surgical procedures.

The increasing demand for minimally invasive procedures is the driving factor that drives the market over the forecast period. Due to increasing demand for minimally invasive procedures, the manufacture and launch of devices like catheters are upsurging and the advancements in technology are also being implemented in the recently launched products. For instance, in May 2024, Penumbra launched the MIDWAY 43 and MIDWAY 62 delivery catheters, which are intended to provide optimal tracking and a stable platform for the delivery of various embolization therapies in the neurovasculature. Based on Penumbra's RED catheter technology, these MIDWAY intermediate catheters are a substantial improvement in the intermediate access device industry.

Market Dynamics: Drivers & Restraints

Increasing demand for minimally invasive procedures

Minimally invasive procedures, which include smaller incisions and less harm to the body, are gradually replacing traditional open surgeries due to their various benefits. These procedures often lead to speedier recovery times, lower risk of complications, less postoperative pain, and shorter hospital stays. As a result, both patients and healthcare practitioners are increasingly adopting these procedures, creating a rise in demand for specialized medical tubing required for their implementation.

Medical tubing is essential in a wide range of minimally invasive treatments in medical specialties such as cardiology, gastrointestinal, urology, and neurosurgery. For instance, catheters and guidewires are critical components in angioplasty and endoscopic treatments. These tubes must be precisely engineered to allow for the successful delivery of medicinal substances or equipment while maintaining patient safety. The number of endoscopy procedures is increasing day by day. This increase in number upsurges the demand for medical tubing. For instance, according a to global survey in 2024, around 32 percent of surgeons reported they performed over 100 endoscopy procedures a year. A further 13.6 percent of surveyed surgeons perform between 50 and 99 endoscopies in a year.

The products of medical tubing in various medical specialties using advanced technologies have been launched in recent times. For instance, in January 2023, Omnivision, a semiconductor solutions manufacturer, introduced the new OVMed OCHTA, an ultra-thin medical-grade cable module for single-use endoscopes. The new module is designed for endoscopes used in minimally invasive surgery, such as spinal, ob/gyn, utero-renal, neuro, ophthalmic, and cardiac operations. The OVMed OCHTA cable modules have a six-wire cable, enabling manufacturers to add their own LED illumination.

High production costs

Factors such as high production costs are expected to hamper the global medical tubing market. Medical tube manufacture comprises a number of sophisticated components and processes, each of which adds to the overall expenditure. High-quality raw materials, restricted regulatory compliance, and innovative manufacturing procedures all contribute to higher production costs. For instance, medical-grade silicone might raise production costs by 20-30% when compared to conventional polymers. Extrusion machinery ranges between $100,000 and $500,000, depending on its complexity and output capacity. The extrusion machinery is vital for ensuring uniformity throughout the tube. All these material costs, extrusion machine costs, and regulatory compliance approval costs sum up to a hefty amount which makes the production high and hampers the market.

Segment Analysis

The global medical tubing market is segmented based on device type, application, structure, end-user, and region.

Catheters segment is expected to dominate the global medical tubing market share

The catheters segment dominates the global medical tubing market owing to the upsurge of minimally invasive procedures, and the increasing number of applications of catheters. Catheters are especially important in domains like cardiology, urology, and gastroenterology, where catheterization is required for diagnostic and therapeutic purposes. One of the primary causes of this growth is the increased frequency of chronic diseases, which demand frequent medical interventions. Catheterization is frequently used to treat and manage conditions such as cardiovascular disease, diabetes, and urinary tract infections. For instance, catheters are increasingly used in treatments such as angioplasty and stent implantation, allowing healthcare personnel to reach blood arteries with minimal harm to adjacent tissues.

For instance, according to the National Institute of Health, heart catheterization is among the most commonly performed heart procedures. In the United States, more than 1,000,000 cardiac catheterization procedures are conducted each year. Moreover, according to the International Society for Infectious Diseases, over 100 million urinary catheters are used globally each year, which equates to approximately 200 catheters being used every minute.

Advances in catheter technology have also contributed significantly to this segment's dominance. Innovations such as biocompatible materials and specific coatings have enhanced catheter performance and safety. There are product recent launches that use revolutionary technologies for manufacturing catheters. For instance, in February 2024, CERENOVUS, Inc., a division of Johnson & Johnson MedTech, announced the launch of the CEREGLIDE 71 Intermediate Catheter, a next-generation intermediate catheter with TruCourse intended for the revascularization of patients suffering from acute ischemic stroke. So, the increasing number of minimally invasive procedures, the increasing number of catheter applications across various medical domains, technological advancements, and the latest product launches make this segment the most dominating segment.

Geographical Analysis

North America is expected to hold a significant position in the global medical tubing market share

This dominance of North America in the global medical tubing market is largely due to the huge demand for medical devices containing tubing, such as catheters, IV lines, and surgical instruments, which are required for a variety of diagnostic and therapeutic treatments, adoption of minimally invasive procedures, technological advancements and presence of top players in the region. The increasing number of catheters used and the upsurge of minimally invasive procedures are observed in this geographic region. For instance, according to the American Heart Association, Inc., Every year, more than 1 million cardiac catheterization procedures are conducted in the United States, with the primary objective of diagnosing and treating patients with suspected or confirmed coronary heart disease and related diseases.

Moreover, according to the International Society for Infectious Diseases, In the United States, an estimated 30 million indwelling urethral catheters are traded each year, with around 20% of hospitalized patients using one at any given time. The recent product launches and technological advancements are observed in this region resulting in the most dominating segment. For instance, in March 2024, Abbott launched the next iteration of its Navitor heart valve technology in the United States. Navitor Vision includes extremely visible markings. These markers aid in identifying depths ranging from 3MM to 4.5MM, hence increasing implant confidence and patient outcomes. The organization received FDA approval for its Navitor system in January 2023. It developed Navitor as the only self-expanding TAVI device that incorporates leaflets within the native valve. This design improves access to coronary arteries, allowing for future treatments to treat coronary artery disease.

The growing number of minimally invasive procedures, catheter applications in a wide range of medical disciplines, technical advances, and the introduction of novel products make North America the most dominating geographical region.

Asia Pacific is growing at the fastest pace in the global medical tubing market

The Asia Pacific region is emerging as the fastest-growing market for global medical tubing. One of the most significant drivers of growth in the Asia Pacific medical tubing market is the rising prevalence of chronic diseases that demand frequent medical treatments. The region is experiencing an increase in health problems like diabetes, cardiovascular disease, and respiratory ailments. As a result, there is an increasing demand for effective treatment alternatives that frequently require specialized medical tubing for operations such as intravenous treatments and minimally invasive surgery.

In recent times, there have been launches of products that use novel technology and help in enhancing treatment efficiency. For instance, Philips, a global pioneer in health technology, announced at India Live 2024 in New Delhi that it has established over 1500 Cath Lab (interventional suite) installations across the Indian subcontinent. Philips also announced the launch of two novel approaches designed to reduce the prevalence of cardiovascular disease (CVD) in India. OmniWire, the world's first solid core pressure wire for coronary artery interventional operations, was launched in India.

Competitive Landscape

The major global players in the global medical tubing market include Saint-Gobain, Freudenberg Medical, W. L. Gore & Associates, Inc., The Lubrizol Corporation, TE Connectivity, Nordson Corporation, Elkem, RAUMEDIC AG, Teknor Apex, Zeus Company LLC among others.

Emerging Players

Vanguard Products Corporation, Bentec Medical, and MicroLumen among others

Key Developments

In October 2024, Boston Scientific Corporation announced that the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation (AF) has received FDA approval, as well as FDA 510(k) clearance for the new FARAVIEW Software, which will be used in conjunction with the FARAPULSE Pulsed Field Ablation (PFA) System to provide visualization for cardiac ablation procedures. These technologies are only compatible with Boston Scientific's existing cardiac mapping technology and the company's latest product, the OPAL HDx Mapping System.
In December 2024, NuGen Medical Devices announced the launch of its InsuJet needle-free insulin delivery system in Canada. It received an initial order of 2,500, followed by a second order of 750 InsuJet starting kits plus consumables. This represents revenue of $670,000.
In October 2024, Husky Technologies and Kriya Medical Technologies Pvt. Ltd. successfully implemented India's first ICHOR-integrated medical system, marking a significant milestone. Kriya's Chennai factory will begin manufacturing 13X100 and 13x75mm blood collection tubes as part of a new agreement.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical tubing market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.2. Increasing Demand for Minimally Invasive Procedures
- 4.1.3. Restraints
- 4.1.4. High Production Costs
- 4.1.5. Opportunity
- 4.1.6. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Device Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 6.1.2. Market Attractiveness Index, By Device Type
6.2. Silicone*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Polyolefins
6.4. Polyvinyl Chloride
6.5. Polycarbonates
6.6. Fluoropolymers
6.7. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Catheters*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Bulk Disposable Tubing
7.4. Drug Delivery Systems
7.5. Biopharmaceutical Laboratory Equipment
7.6. Others

8. By Structure

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Structure
- 8.1.2. Market Attractiveness Index, By Structure
8.2. Single-lumen*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Co-extruded
8.4. Multi-lumen
8.5. Tapered or bump tubing
8.6. Braided tubing

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Device Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Structure
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. The U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Device Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Structure
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. UK
  - 10.3.7.3. France
  - 10.3.7.4. Italy
  - 10.3.7.5. Spain
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Device Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Structure
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Device Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Structure
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Device Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Structure
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Saint-Gobain*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Freudenberg Medical
12.3. W. L. Gore & Associates, Inc.
12.4. The Lubrizol Corporation
12.5. TE Connectivity
12.6. Nordson Corporation
12.7. Elkem
12.8. RAUMEDIC AG
12.9. Teknor Apex
12.10. Zeus Company LLC

LIST NOT EXHAUSTIVE